オルバヘルスケアホールディングス(株)
株価チャート
2026/10/09 19:27 更新株価トレンド
2026/10/09 19:27 更新株価・取引詳細
2026/10/09 19:27 更新株価
取引
株主構成
2026/10/01 更新配当履歴
2026/10/04 更新| 年度 | 配当金 | 変化 |
|---|---|---|
| 2026 | ¥80 | 0.0% |
| 2025 | ¥80 | 0.0% |
| 2024 | ¥80 | +14.3% |
| 2023 | ¥70 | +16.7% |
| 2022 | ¥60 | - |
財務パフォーマンス
2026/10/04 更新売上・利益
利益率
キャッシュフロー
財務健全性
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| 損益計算書 | |||
| 売上高 | ¥1,080億 | ¥1,105億 | ¥1,186億 |
| 売上総利益 | ¥125億 | ¥130億 | ¥136億 |
| 営業利益 | ¥21億 | ¥22億 | ¥22億 |
| 経常利益 | ¥22億 | ¥22億 | ¥23億 |
| 当期純利益 | ¥15億 | ¥14億 | ¥15億 |
| EPS | - | ¥234.90 | ¥251.68 |
| 営業利益率 | 1.92% | 1.95% | 1.88% |
| 貸借対照表 | |||
| 総資産 | ¥400億 | ¥409億 | ¥432億 |
| 純資産 | ¥91億 | ¥103億 | ¥114億 |
| 総負債 | ¥309億 | ¥306億 | ¥319億 |
| 現金 | ¥32億 | ¥24億 | ¥27億 |
| 有利子負債 | ¥13億 | ¥19億 | ¥16億 |
| 自己資本比率 | 22.75% | 25.26% | 26.31% |
| D/Eレシオ | 0.14 | 0.19 | 0.14 |
| キャッシュフロー | |||
| 営業CF | ¥24億 | -¥7億 | ¥21億 |
| 投資CF | -¥2億 | -¥3億 | -¥7億 |
| 財務CF | -¥12億 | ¥2億 | -¥11億 |
| フリーCF | ¥20億 | -¥9億 | ¥16億 |
| 効率性 | |||
| ROE | 16.88% | 13.69% | 13.19% |
| ROA | 3.84% | 3.46% | 3.47% |
最新IR情報
-
株式交換による1株に満たない端数の処理に伴う自己株式の買取りに関するお知らせ
株式交換実施に伴い、端数処理分として167株の自社株を買取り。買取金額は終値価格...
詳細を読む -
オルバヘルスケアホールディングス株式会社 2026年6月期 決算短信
2026年6月期の連結売上高は126,595百万円(前年同期比3.2%増)、営業...
詳細を読む -
オルバヘルスケアホールディングス株式会社 2026年6月期 決算短信
2026年6月期の連結売上高は126.6億円、営業利益は1.68億円、親会社株主...
詳細を読む -
取締役に対する株式報酬制度の改定に関するお知らせ
株式報酬制度の改定を決議。経営統合に伴い、対象となる取締役を「株式報酬制度の対象...
詳細を読む -
取締役に対する株式報酬制度の改定に関するお知らせ
臨時株主総会の開催日(2026年7月28日10:00開始、岡山市ホテルグランヴィ...
詳細を読む
最新ニュース (5件)
企業情報
会社概要
OLBA DVx HEALTHCARE, Inc., together with its subsidiaries, operates as a distributor of medical equipment and pharmaceuticals in Japan. The company operates through three segments: Medical Equipment Business, Specialty Product Delivery (SPD) Business, and Nursing Care Products Business. The Medical Equipment Business segment engages in the wholesale of medical equipment comprising artificial joints, coronary stents, steel instruments, osteosynthesis materials made of metal and ceramics, ultrasonic scalpels, and pacemakers and catheters related to examination, diagnosis, and treatment of the heart and blood vessels; X-ray fluoroscopy and CT equipment for tumor and embolism treatment, and endoscopes for cancer treatment; and diagnostic imaging equipment, such as MRI and CT to ventilators, and intraoperative monitors, as well as operating room equipment, including shadowless lights. This segment also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemical, immunological, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The Specialty Product Delivery (SPD) Business segment provides inventory management, medical material masters and data analysis, and purchase management services. The Nursing Care Products Business segment engages in the sale and rental of nursing care equipment; the sale of welfare equipment, such as portable toilets and bathing chairs; and home renovation works, as well as provides nursing care services. The company was formerly known as OLBA HEALTHCARE HOLDINGS, Inc. and changed its name to OLBA DVx HEALTHCARE, Inc. in September 2026. OLBA DVx HEALTHCARE, Inc. was founded in 1921 and is headquartered in Okayama, Japan.